Post Option B+ implementation programme in Nigeria: Determinants of adherence of antiretroviral therapy among pregnant women with HIV
Author(s) -
Olumuyiwa Omonaiye,
Snezana Kusljic,
Patricia Nicholson,
Mohammadreza Mohebbi,
Elizabeth Manias
Publication year - 2019
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2019.02.014
Subject(s) - medicine , logistic regression , odds ratio , confidence interval , cross sectional study , pregnancy , antiretroviral therapy , demography , human immunodeficiency virus (hiv) , odds , environmental health , family medicine , viral load , genetics , pathology , sociology , biology
Nigeria has the highest rate of mother to child transmission of HIV (MTCT) in the world. By 2015, all Global Plan priority countries, except Nigeria, had adopted the Option B+ programme. Nigeria finally adopted Option B+ in 2016 with full implementation reported in 2017. We examined adherence to antiretroviral therapy (ART) among pregnant women since the rollout of Option B+ in Nigeria.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom